STOCKS TELEGRAPH

Author: Hassan Masood

  • BIOLASE, Inc. (BIOL) Stock on a Rising Trajectory in Aftermarket, Here’s Why

    BIOLASE, Inc. (BIOL), a company that develops, manufactures, markets, and sells laser systems, has surged 16.31% in aftermarket trading session. As a result, BIOL stock is changing hands at $0.49 at the time of the writing. The rise is attributable to the receipt of a 180-day extension to meet the minimum bid price requirement. On Tuesday, BIOL closed the day at $0.42 after declining 4.78% during regular trading hours.  

    Why BIOL Increasing?

    On Tuesday, BIOL announced that it had received written notification from NASDAQ. The notification granted the company’s request for a 180-day extension to regain compliance with minimum bid price requirements. The company now has got the time until the 23rd May 2022 to regain compliance with the rule of the bid price. The extension notice served to the company has had no immediate effect on the continued listing status of the company’s common stock, which has remained listed on the NASDAQ capital market.

    Q3 2021 Financial Results

    On 10th November, BIOL announced financial results for the third quarter of the fiscal year 2021. The quarter ended on 30th September 2021. The company generated net revenue of $9.53 million during the quarter against $6.53 million for the same period of 2020. The total operating expenses bore by the company during the period were $7.49 million against $5.94 million for the same period of 2020. The net loss suffered by the company during the quarter was $3.27 million against the net income of $12,000. The net loss per basic and diluted share during the quarter was $0.02 against $0.21 for the same quarter of 2020. The company had cash and cash equivalents of $33.38 million on 30th September 2021.

    Executive Commentary

    John Beaver, President and Chief Executive Officer of BIOL, while commenting on the results said that the quarterly performance continues to reflect the rising demand for its industry-leading dental lasers. He said that the dental lasers aim to provide a better standard for the care of dental procedures and seek to ensure a safer experience which reduces the risk of future procedure and business disruptions.

    Future Outlook for BIOL

    The last three months have seen BIOL stock decline by more than 40%. The prime reason for that is the uncertainty associated with the stock as the pandemic is imparting its influence on the market. However, the analysts believe that the company has the potential to come out of this negative trend in near future.

  • MediciNova, Inc. (MNOV) Stock Skyrocketed on Tuesday, Here’s the Reason

    MediciNova, Inc. (MNOV), a biopharmaceutical company, has plunged 1.81% in aftermarket trading session. Consequently, MNOV is trading at $4.41 at the time of the writing. On Tuesday, MNOV closed the day at $4.42 after surging 43.97% during regular trading hours. The consistent increase could be attributed to a positive development regarding a preclinical study of MN-166.

    Why MNOV Rising?

    On Monday, MNOV announced the results from a pre-clinical study of MN-166 in a combination with the PD-1 inhibitor. The results were presented at the 26th annual meeting of the Society for Neuro-Oncology (SNO). The data was taken from a study involving MN-166 and a PD-1 inhibitor in a glioblastoma pre-clinical model. After the GBM orthotopic tumours were injected, a mouse was treated with the control with a PD-1 antibody alone as well as in combination with MN-166. The median survival for the mice which was treated with PD-1 antibody was 28 days. For the combination of MN-166 and PD-1 antibody, the median survival increased to 66 days.

    Q3 2021 Financial Highlights

    On 12th November, MNOV released the financial results for the third quarter of the fiscal year 2021. The quarter ended on 30th September 2021. The company had cash and cash equivalents of $75.02 million on 30th September 2021. The total revenue generated by the company during the period was $37,500. The total operating expenses for the three months were $3.63 million against $3.73 million for the same period of 2020. The comprehensive loss suffered by the company during the quarter was $3.58 million against $3.70 million for the same period of 2020. The net loss per basic and diluted share for the period was $0.07 against $0.08 for the same quarter of 2020.

    Executive Commentary

    Yuichi Iwaki, M.D., Ph.D., President and Chief Executive Officer of MNVO, while commenting on the results said that even though the company incurred significant losses since its inception, he remains optimistic keeping in mind the future scenario for the company. He said that the company would continue with certain of the product development programs and in the long-term is aiming to expand its research and development program.

    Future Outlook for MNOV

    The last three months have seen MNOV stock increase by more than 15%, a positive sign when compared with the results for 12 months. Analysts hope that the positive developments associated with MN-166 could take the stock even further in the future to come. So, potential investors should keep a close eye on the stock.

  • Zoom Video Communications, Inc. (ZM) Stock in Decline Despite Robust Quarterly Results

    Zoom Video Communications, Inc. (ZM) Stock in Decline Despite Robust Quarterly Results

    Zoom Video Communications, Inc. (ZM), a company providing a video-first communications platform, has declined 6.80% in aftermarket trading session. Consequently, ZM stock is trading at $225.80 at the time of the writing. On Monday, ZM closed the day at $242.28 after declining 3.59% during regular trading hours. The company has faced a consistent decline despite the release of outstanding quarterly results.

    ZM Q3 2021 Financial Highlights

    On Monday, ZM released the financial results for the third quarter of the fiscal year 2021. The quarter ended on 30th September 2021. The company had cash and cash equivalents of $1.32 billion on 30th September 2021. The total revenue generated by the company during the period was $1.05 billion against $777.19 million for the same period of 2020. The total operating expenses for the period were $488.94 million against $326.22 million for the same period of 2020. The net income generated by the company during the period was $340.38 million against $198.64 million for the same period of 2020. The net income per basic and diluted share for the period was $1.14 and $1.11 respectively against $0.70 and $0.66 for the same three-month period of 2020.

    Financial Outlook

    Alongside the financial results, ZM also reported the financial outlook for the upcoming quarter and complete fiscal 2021. The company believed that the total revenue for the fourth quarter of 2021 would stand between $1.051 and $1.053 billion. The non-GAAP income from the operations was expected in the range of $361 million and $363 million. The non-GAAP diluted EPS was estimated to stand between $1.06 and $1.07. For the full fiscal year 2021, the total revenue was expected to range between $4.079 billion to $4.081 billion. The non-GAAP income from operations was expected to lie between $1.598 billion and $1.600 billion. The non-GAAP diluted EPS was expected to range between $4.84 and $4.85.

    Executive Commentary

    ZM founder and CEO, Eric S. Yuan, while commenting on the results said that the company has continued and would continue to deliver happiness to its customers through innovation and dedication. He further said that looking forward; the company expects to close the year on a high in terms of financial performance. He expressed his pleasure over the fact that the company is on its way to becoming the indispensable platform for different sections of society to connect and collaborate.  

    What Lies Ahead for ZM?

    Statistics reveal that ZM stock has faced an abysmal performance during the last 12 months. That is quite surprising; given the fact that how the company has performed during the pandemic. But analysts believe that the strong competition to the company other market giants have caused its stock to suffer. In the long run, however, ZM stock is expected to depict strong performance.

  • Soligenix, Inc. (SNGX) Stock Soaring in Aftermarket, Here’s Why

    Soligenix, Inc. (SNGX) Stock Soaring in Aftermarket, Here’s Why

    Soligenix, Inc. (SNGX), a late-stage biopharmaceutical company, has surged 14.35% in aftermarket trading session. Consequently, SNGX is trading at $0.95 at the time of the writing. The market speculations that the company’s RiVax® Vaccine is close to getting the approval from US FDA. On Monday, SNGX closed the day at $0.83 after declining 2.98% during the mid-day session. Let’s discuss some recent developments related to SNGX stock.

    Q3 2021 Financial Results

    On 12th November, SNGX released the financial results for the third quarter of the fiscal year 2021. The quarter ended on 30th September 2021. The company generated revenue of $0.2 million during the quarter against $0.6 million for the same period of 2020. The basic net loss suffered by the company during the period was $3.6 million (or $0.09 per basic and diluted share) against $1.8 million (or $0.06 per basic and diluted share) for the same period of 2020. The research and development expenses for the period were $2.5 million against $1.3 million for the same period of 2020. The general and administrative expenses bore by the company during the quarter were $0.9 million against $0.8 million for the same quarter of 2020.

    Recent Accomplishments of SNGX

    Alongside the financial results, SNGX also reported its recent accomplishments. The company had been granted a Pediatric Investigation Plan (PIP) product-specific waiver in the United Kingdom on 8th November. It announced the publication of pre-clinical immunogenicity studies for RiVax® during the early days of November. The study highlighted the enduring protection for at least 12 months after the vaccination. In September, the company announced the expansion in Phase 3 FLASH study in CTCL.

    Executive Commentary

    Christopher J. Schaber, Ph.D., President and Chief Executive Officer of SNGX, while commenting on the results said that the company has approximately $29 million in terms of cash. This capital would aid the company in achieving its upcoming milestones. He hoped that the company would continue to explore several of the strategic options, which include partnership, mergers, and acquisition opportunities.

    Future Outlook for SNGX

    The last 12 months have seen SNGX decline by more than 60%, the prime reason being the uncertainty associated with the RiVax vaccine candidate of the company. However, the analysts are hopeful that once the vaccine would get the nod of approval from regulatory authorities, tables would turn for SNGX stock.

  • iSpecimen, Inc. (ISPC) Stock on a Consistent Rise, Here’s the Reason

    iSpecimen, Inc. (ISPC) Stock on a Consistent Rise, Here’s the Reason

    iSpecimen, Inc. (ISPC), a technology-driven company, has surged 46.73% in aftermarket trading session. Consequently, ISPC stock is trading at $13.03 at the time of the writing. On Monday, ISPC closed the day at $8.88 after a gigantic increase of 80.49% during the mid-day session. This consistent rise is attributable to the selection of the company by the US government to supply critical human biospecimens.

    Why ISPC Rising?

    On Monday, ISPC announced that it had been contracted to support the new and advanced research on the COVID-19 pandemic. The research was to be aimed at seeking insights into the transmissibility, variants, outcomes, and testing validity in a major section of the society. During the last 10 months, ISPC has announced partnerships with many research and health care organizations on a variety of projects which required the COVID-19 samples. The company started working on the impacts of the pandemic soon after the outbreak last year. The company provided CDC with 600 SARS-CoV-2-positive serum samples and 100 negative serum samples.

    Q3 2021 Financial Results

    On 4th November, ISPC reported the financial results for the third quarter of the fiscal year 2021. The quarter ended on 30th September 2021. The company had cash of $9.79 million on 30th September 2021. The total revenue generated by the company during the period was $2.71 million against $2.25 million for the same quarter of 2020. The company bore total operating expenses of $4.17 million against $2.97 million for the same period of 2020. The net loss suffered by the company during the quarter was $1.55 million against $1.24 million for the same quarter of 2020. The net loss per basic and diluted share for the three months was $0.22 against $1.33 for the same three month period of 2020.

    Executive Commentary

     Christopher Ianelli, MD, Ph.D., CEO, and President of ISPC, while commenting on the results said that the company has achieved strong growth during the quarter, as a result of which, there was an expansion in market penetration. For him, these and similar efforts by the company have contributed to a strong quarter, as depicted from the results. He hoped that the efforts of the company would allow it to increase the value proposition for the users and suppliers and would further increase its sales momentum.

    Future Outlook for ISPC

    The last three months have proved to be outstanding for ISPC stock as it has surged more than 50% during the period. The prime reason for that is the increased reliance on innovation by the company, which in turn has gradually built the shareholder interest. Analysts believe that a continuation of these sorts of policies would yield the company numerous benefits in the future to come.

  • Here’s the Reason Why Qualigen, Inc. (QLGN) Stock is on a Boom

    Here’s the Reason Why Qualigen, Inc. (QLGN) Stock is on a Boom

    Qualigen, Inc. (QLGN), a biotechnology company, has soared 108.80% in aftermarket trading session. Consequently, QLGN stock is trading at $2.61 at the time of the writing. On Monday, QLGN closed the day at $1.25 after surging 25.62% during regular trading hours. The constant surge could be attributed to the strong quarterly results.

    Why QLGN Surging?

    On 15th November, QLGN released the financial results for the third quarter of the fiscal year 2021. The quarter ended on 30th September 2021. The company generated total revenue of $1.15 million during the quarter against $0.83 million for the same period of 2020. The total expenses bore by the company during the three months were $5.96 million against $4.55 million for the same period of 2020. The net loss suffered by the company during the period was $2.85 million (or $0.10 per basic and diluted share) against $8.11 million (or $0.41 per basic and diluted share) for the same period of 2020. The company had cash and cash equivalents of $12.31 million on 30th September 2021.

    Executive Commentary

    Michael S. Poirier, QLGN Chairman, CEO, and President, while commenting on the results said that the company is encouraged by what it believes to be a strong quarter, as there was a 38% year-over-year increase in revenue. He further said that the company would continue to be encouraged by this increase. He hoped that the developments in the therapeutics business would start paying the company more dividends in long run soon.

    Publication Validating FastPack® IP Diagnostics Test

    On 19th October, QLGN announced the publication of a study in the peer-reviewed journal, by the name of Diagnostics. The publication validated the Company’s point of care FastPack® IP diagnostics test as compared to a laboratory method that determined thyroid-stimulating hormone (TSH) levels in the blood. The study provided validation behind the evidence which supported the reliability of FastPack compared to laboratory tests.

    Future Outlook for QLGN

    Statistics reveal that during the last 12 months, QLGN stock has declined more than 50%. But keeping in view the more recent times, it appears that that stock is leaping forward, even though slowly. Analysts believe that QLGN stock’s recent performance could impart a significant influence upon potential investors to make investments in Qualigen.

  • Rio Tinto Group (RIO) Stock Taking Small Steps in Positive Direction

    Rio Tinto Group (RIO) Stock Taking Small Steps in Positive Direction

    Rio Tinto Group (RIO), a company engaged in exploring, mining, and processing mineral resources, has steadily increased by 0.016% in aftermarket trading session and is trading at $60.72 at the time of the writing. On Friday, RIO closed the day at $60.71 after increasing 1.35% during regular trading hours. The steady but constant increase is attributable to the ownership of Diavik Diamond Mine.

    Why RIO Rising?

    On Thursday, RIO announced that it had taken full control of Canada’s biggest diamond mine, namely the Diavik Diamond Mine. The mine was previously owned by billionaire Dennis Washington. The company already had a 60% stake in the mine. It has bought the share previously held by the Dominion Diamond Mines. Dominion filed for insolvency protection in 2020 after the pandemic harmed the diamond trade throughout the globe.

    Increase Low Carbon Al Production

    On 17th November, RIO announced that it is investing $87 million to increase the production of low carbon aluminium with 16 new smelting cells at the AP60 smelter in Quebec, Canada. As a result of the investment in low carbon aluminium production, the production at smelter would increase around 45% and also would provide a secure future to approximately 100 employees at the site. The company has projected the global aluminium growth to stand at a rate of 3.3% per annum throughout the next decade with the ever-increasing demand.

    Investment in InoBat Auto

    On 16th November, RIO announced that it is supporting the development of the battery ecosystem in Europe by investing in Inobat Auto (InoBat). InoBat is a European based battery technology and manufacturing company. As a result of the investment, the company would be able to support the completion of InoBat’s research and development centre and pilot battery line in Voderady, Slovakia. A Memorandum of Understanding signed in May served as the precursor to the investment.

    Future Outlook for RIO

    Statistics reveal that the last few months have not been up to the mark for RIO stock. The prime reason for that is the impact of the pandemic on mining activities. However, the recent policy announcements by the company could serve as a positive stimulant for the RIO stock in upcoming quarters.

  • Muscle Maker, Inc. (GRIL) Stock Rallying in Aftermarket, Here’s the Reason

    Muscle Maker, Inc. (GRIL) Stock Rallying in Aftermarket, Here’s the Reason

    Muscle Maker, Inc. (GRIL), a company owning, operating, and franchising Muscle Maker Grill and Healthy Joe’s restaurants, has gained an increase of 6.25% in aftermarket trading session. Consequently, GRIL stock is trading at $1.19 at the time of the writing. The new 12-month price estimate of the stock presented by some websites has served as a stimulant for this surge. On Friday, GRIL closed the day at $1.12 after declining 2.61% in regular trading hours. Let’s discuss some recent developments related to GRIL stock.

    GRIL Definitive Agreement

    On Thursday, GRIL announced that it had entered into a definitive agreement with US institutional investors for a private placement of 6,772,000 shares of common stock with the warrants to purchase 6,772,000 shares of common stock. Besides, the agreement also deals with 4,058,305 pre-funded warrants. Each pre-funded warrant was excisable for one share of common stock, together with Common Warrants to purchase up to 4,058,305 shares of common stock. The Private Placement was expected to close on or about November 22, 2021.

    Q3 2021 Financial Results

    On 15th November, GRIL released the financial results for the third quarter of the fiscal year 2021. The quarter ended on 30th September 2021. The company had $3.61 million in terms of cash on 30th September 2021. The total revenue generated by the company during the period was $3.35 million against $1.15 million for the same period of 2020. The total costs and expenses for the period were $4.98 million against $1.88 million for the same period of 2020. The net loss bore by the company during the quarter was $0.43 million against $0.66 million for the same quarter of 2020. The net loss per basic and diluted share for the quarter was $0.02 against $0.09 for the same quarter of 2020.

    Executive Commentary

    Spanos Stephen Andrew, Director of GRIL, while commenting on the results said that the company has depicted a tremendous performance during the quarter. For him, the healthy-inspired restaurant concept delivers a highly differentiated customer experience. He hoped that the company would be able to mimic, and even further improve, the performance it has depicted during the quarter.

    Future Outlook for GRIL Stock

    A closer look a statistics reveals that GRIL stock has not experienced much volatility during the last few months. Analysts believe that the GRIL is in a good position to leave a mark on the market in near future. Hence, potential investors should keep a close eye on fluctuations in GRIL stock.

  • Here’s the Reason Why Vinco Ventures, Inc. (BBIG) Stock is Leaping Forward in Aftermarket

    Here’s the Reason Why Vinco Ventures, Inc. (BBIG) Stock is Leaping Forward in Aftermarket

    Vinco Ventures, Inc. (BBIG), a company involved in consumer product research and development, manufacturing, sales, and fulfillment, has soared 10.88% in aftermarket trading session. Consequently, BBIG stock is trading at $4.28 at the time of the writing. The increase was attributable to the announcement of the release date of quarterly results by the company. On Friday, BBIG closed the day at $3.86 after declining 2.77% during the mid-day session.

    Why BBIG Stock Increasing?

    On Friday, BBIG announced that it would release the financial results for the third quarter of fiscal 2021, which ended 30th September 2021, on 22nd November 2021. The company said that the management would hold the conference call and a webcast to shed a light on the company’s third-quarter results and major business developments which have imparted influence over the company.

    Filing of Registration Statement

    On 8th November, BBIG announced the filing of form 10 registration statement with US SEC related to the planned spin-off of Cryptyde Inc. The spin-off was to cause Cryptyde a publicly-traded NASDAQ listed company having a ticker symbol of TYDE. The Vinco was to continue under the ticker of BBIG on NASDAQ after the completion of the planned spin-off and the merger with Zash Global Media and Entertainment Corp.

    Q2 2021 Financial Highlights

    In late August, BBIG announced the financial results for the second quarter of the fiscal year 2021. The quarter ended on 30th June 2021. The company had cash and cash equivalents of $74.75 million on 30th June. The net revenue generated by the company during the quarter was $2.69 million against $5.17 million for the same period of 2020. The operating loss bore by the company during the quarter was $4.97 million against $1.20 million for the same period of 2020. The net loss suffered by the company during the quarter was $183.66 million (or $5.13 per basic and diluted share) against $1.62 million (or $0.18 per basic and diluted share) for the same period of 2020.

    Future Outlook for BBIG Stock

    Statistics reveal that during the last three months, BBIG stock has increased more than 55%. The prime reason for that is the excellent business strategies imparted by the company in the form of business expansion plans. Analysts believe that the continuation of such policies would greatly aid the company in the long run.

  • Greenland Technologies Holding Corp. (GTEC) Stock in Decline After a Robust Friday

    Greenland Technologies Holding Corp. (GTEC), a company that develops and manufactures transmission and drivetrain systems for material handling machinery and electric vehicles, has declined 9.91% in aftermarket trading session. Consequently, GTEC stock is trading at $8.91 at the time of the writing. The decline could be attributed to the profit-taking actor after the company surged 89.46% during Friday’s regular trading hours and closed the day at $9.89. The reason for this monumental surge was the launch of a second electric industrial vehicle line.

    Why GTEC Surged on Friday?

    On Friday, GTEC announced the launch of its second electric industrial vehicle line, namely the GEL-1800 Electric Loader. Before that, the company has already launched the GEF-series electric lithium forklift line. GEL-1800 Electric Loader contains a 141 KWh lithium battery, which provides environment friendliness. It boasts a rapid 2-hour charge and is capable to answer the basic issues arising in modern facility managers.

    Q3 2021 Financial Highlight

    On 11th November, GTEC announced the financial results for the third quarter of the fiscal year 2021. The quarter ended on 30th September 2021. The company generated revenues of $23.08 million during the quarter against $16.52 million during the same quarter of 2020. The total operating expenses of the period were $3.04 million against $1.15 million for the same period of 2020. The company generated a net income of $1.25 million during the quarter against $0.46 million for the same period of 2020. The net income per basic and diluted share for the period was $0.09 against $0.02 for the same period of 2020. The company had $9.02 in terms of cash and cash equivalents on 30th September 2021.

    Outlook for FY2021

    Alongside the financial results, GTEC also reported the financial outlook for the upcoming quarter. The company believes that for the full year 2021, the total revenues are expected to range between $90 million to $100 million. That is an increase of 35% to 49% year over year basis from 2020. The company also said that the outlook could change in the future, as the uncertainties could result from how the pandemic develops across the globe.

    What’s Ahead for GTEC Stock?

    During the last 12 months, GTEC stock has gained an increase of more than 100%. That reflects the investor interest in the company, which is finding its innovative strategies worth investing in. Hence, potential investors should keep a close eye on the developments related to GTEC stock to make their investments count soon.